Storage Condition
Refer MSDS for complete information
Synonyms
(R)-Cinacalcet-D3, 1228567-12-1
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
(R)-Cinacalcet-D3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
(R)-Cinacalcet-D3 usage and description
(S)-Cinacalcet-D3 is a deuterated version of the medication Cinacalcet, used in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease and hypercalcemia in patients with parathyroid carcinoma. The deuterium substitution in (S)-Cinacalcet-D3 allows for better identification and quantification of the drug in biological samples during clinical trials.
The chemical formula of (S)-Cinacalcet-D3 is C22H21D3F2N and it has a molecular weight of 346.45 g/mol. It works by binding to the calcium-sensing receptor on the parathyroid gland, which reduces the secretion of parathyroid hormone and decreases serum calcium levels.
The recommended dosage of (S)-Cinacalcet-D3 varies depending on the individual patient's needs and medical condition. It is typically taken orally, with or without food, once daily. The drug should be used with caution in patients with moderate to severe hepatic impairment, as it can increase the risk of adverse effects.
(S)-Cinacalcet-D3 is generally well-tolerated, but some side effects may occur. These can include nausea, vomiting, diarrhea, headache, and dizziness. Patients should inform their healthcare provider if they experience any adverse effects while taking the medication.
Overall, (S)-Cinacalcet-D3 is a useful medication for the treatment of hyperparathyroidism and hypercalcemia. Its deuterated form allows for more accurate measurement and analysis during clinical trials, which can lead to improved drug development and patient outcomes.
